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Abstract
Background: Salmonella enterica serovar Enteritidis (S. Enteritidis) has emerged as one of the most important food-
borne pathogens for humans. Lipopolysaccharide (LPS), as a component of the outer membrane, is responsible for
the virulence and smooth-to-rough transition in S. Enteritidis. In this study, we screened S. Enteritidis signature-tagged
transposon mutant library using monoclonal antibody against somatic O9 antigen (O9 MAb) and O9 factor rabbit
antiserum to identify novel genes that are involved in smooth-to-rough transition.
Results: A total of 480 mutants were screened and one mutant with transposon insertion in rfbG gene had smooth-to-
rough transition phenotype. In order to verify the role of rfbG gene, an rfbG insertion or deletion mutant was
constructed using λ-Red recombination system. Phenotypic and biological analysis revealed that rfbG insertion
or deletion mutants were similar to the wild-type strain in growth rate and biochemical properties, but the
swimming motility was reduced. SE Slide Agglutination test and ELISA test showed that rfbG mutants do not
stimulate animals to produce agglutinating antibody. In addition, the half-lethal dose (LD50) of the rfbG deletion
mutant strain was 106.6 -fold higher than that of the parent strain in a mouse model when injected intraperitoneally.
Conclusions: These data indicate that the rfbG gene is involved in smooth-to-rough transition, swimming motility and
virulence of S. Enteritidis. Furthermore, somatic O-antigen antibody-based approach to screen signature-tagged transposon
mutants is feasible to clarify LPS biosynthesis and to find suitable markers in DIVA-vaccine research.
Keywords: rfbG gene, S. Enteritidis, Signature-tagged mutagenesis (STM), Smooth-to-rough transition, O9 MAb
Background
Salmonella enterica serovar Enteritidis (S. Enteritidis,
SE) has emerged as one of the most important food-
borne pathogens for humans, with poultry meat and
eggs being the most common sources of human S.
Enteritidis food-borne infections [1]. Young chicks
showed high mortality rate when infected with S.
Enteritidis. However, in adult chickens, S. Enteritidis
usually leads to symptomless carriage, and is able to
colonize the tissues of the ovary and oviduct of egg-
laying hens which result in egg contamination [2, 3].
Above all, S. Enteritidis constitutes a risk for public
health.
In Salmonella, the lipopolysaccharide (LPS), as a sig-
nificant component of the outer membrane, is respon-
sible for virulence, smoothness and for mounting cross
reactivity [4]. LPS is composed of three major struc-
tures—a core polysaccharide unit; the O-antigen, a poly-
saccharide consisting of repeating units of sugars that
extend from the cell surface; and lipid A, a potent acti-
vator of the immune response, which anchors the LPS
to the outer membrane [5]. Mutations in genes that are
required for the synthesis of the LPS often result in a
truncated LPS [4]. Mutant strains harboring incomplete
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LPS due to its truncation in the polysaccharide structure
may have a smooth-to-rough transition [6]. Until now,
some LPS deficient mutants (for instance, rfaJ, rfaL or
rfc.) have been used to prevent infection caused by fowl
typhoid, Salmonella Typhimurium and Salmonella
Choleraesuis [4, 7, 8]. The purpose of this study was to
identify novel factors that are involved in smooth-to-
rough transition in S. Enteritidis.
Signature-tagged mutagenesis (STM) is a powerful tool
to identify genes that are associated with a particular
phenotype. The STM technique has been applied in sev-
eral pathogens to identify conditionally essential genes
during infection [9–11]. In previous studies in our la-
boratory, Geng et al. screened an STM bank of 1800 S.
Gallinarum biovar Pullorum mutants and identified the
genes essential for its survival in chickens. The attenu-
ation of 10 mutants was confirmed by in vivo and in
vitro competitive index (CI) studies. One highly attenu-
ated spiC mutant was further characterized as a candi-
date vaccine [11].
Different serotypes of Salmonella have different O
antigens. O antigens are used for serotyping of Sal-
monella. O9 antigen is one of the antigens produced
on Salmonella Enteritidis. Salmonella Enteritidis with
smooth phenotype have O9 antigen and therefore can
be agglutinated by O9 antibody [12, 13]. However,
Salmonella Enteritidis without O9 antigen would
show rough phenotype. In this study, we used home-
made monoclonal antibody against somatic O9 anti-
gen (O9 MAb) [14] and commercial O9 factor rabbit
antiserum to screen S. Enteritidis signature-tagged
transposon mutants to identify novel factors involved
in smooth-to-rough transition.
Methods
Bacteria, plasmids, primers and grow media
Bacterial strains, plasmids and primers used in this study
are listed in the Table 1. Wild-type Salmonella Enteritidis
strain C50041 was used in this study [15]. SE
C50041ΔspiC, which was constructed by suicide plasmid
in previous studies in our laboratory, was used as the re-
cipient strain to make the mutant library in this study
[16]. The plasmid pUT mini-Tn5Km2 (Cm) was con-
structed by inserting CmR gene into pUT mini-Tn5Km2.
Bacteria were grown in LB broth (Difco). When needed,
this medium was supplemented with 1.5% (w/v) Bacto-
agar, ampicillin (Amp, 100 μg/ml), kanamycin (Km, 50 μg/
ml) and chloromycetin (Cm, 40 μg/ml).
Construction of the transposon mutant library
According to the PCR-based STM working scheme,
pUT mini-Tn5Km2(Cm) was used for transformation
Table 1 Bacteria, plasmids and primers used in this study
Material Description/purpose Source or reference
Strains
SE C50041 Salmonella enterica serovar Enteritidis;
Wild-type; smooth
Hu et al., 2013 [15]
SE C50041ΔspiC ΔspiC mutant of SE C50041; Recipient
strain; smooth
Zeng et al., 2015 [16]
E. coli. χ7213-pir Donor strain Gift from R. Curtiss III
E. coli. DH5α For cloning Purchased from Takara company
SE C50041ΔspiC - rfbG::Tn5Km2(Cm) rfbG transposon mutant of SE C50041ΔspiC This study
SE C50041ΔrfbG ΔrfbG mutant of SE C50041 by λ-Red
recombination system
This study
S. Pullorum S06004 Negative control in the motility assay Geng et al., 2009 [30]
Plasmids
pUT mini-Tn5Km2(Cm) For cloning Constructed and stored in our laboratory
pKD3 Cm cassette template Datsenko & Wanner, 2000 [17]
pKD46 λ-Red recombinase expression Datsenko & Wanner, 2000 [17]
pCP20 FLP recombinase expression Datsenko & Wanner, 2000 [17]
Primers
Y linker 5’- CTGCTCGAATTCAAGCTTCT -3’ This study
P6U 5’- GAGCTCGAATTCGGCCTAG -3’ This study
rfbG forward 5’- AGGGCTGTGGGAAAAAGGTAAAGCTCCGTGGA
AAACCTGGGAGTAAGTAGTGTGTAGGCTGGAGCTGCTTC -3’
This study
rfbG reverse 5’- CTCACGCAGGTTATTTGCTGTCATTACT
TTGATTCCTTAAACTTATTTTCCATATGAATATCCTCCTTAG -3’
This study
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into E. coli. χ7213-pir, which required 2,6-diaminopime-
lic acid (DAP) for growth. The transformants were
plated on selective LB agar plates containing Amp, Km,
Cm and DAP. Thus the donor strain was generated.
Conjugation was performed between the donor strain
and the recipient strain SE C50041ΔspiC strain as de-
scribed previously [11].
Briefly, 400 μl of the donor was mixed with 400 μl of
the recipient. The mixture was immobilized on a
0.45 μm pore-size membrane filter placed on LB agar at
30 °C for 24 h. Transconjugants were recovered in 2 ml
phosphate-buffered saline (PBS) and a 100 μl aliquot
was plated on LB agar containing Km and Cm. All the
potential conjugants were analysed for exclusive pUT
mini-Tn5Km2(Cm) insertion by confirmation of Amp
sensitivity. Each transconjugant was grown in a 96-well
plate and stored in LB containing 20% glycerol at -80 °C
for further use.
Screening rough strains from mutant library
Frozen plates of the SE C50041ΔspiC transposon mu-
tants were defrosted and subcultured by transferring
20 μl from each well to a new 96-well plate containing
180 μl of LB (containing Km and Cm). Plates were incu-
bated overnight in a shaking incubator at 50 rpm at 37 °C.
Subcultured strains were grown on LB agar containing
Km and Cm at 37 °C for 16 h.
The slide agglutination tests were performed using O9
MAb developed previously in our laboratory and O9 fac-
tor rabbit antiserum (SSI®SALMONELLA ANTISERA,
Denmark). AS handbook indicated, mutant culture from
LB agar medium was mixed homogeneously with 1 drop
of PBS and 1 drop of the O9 MAb or O9 factor rabbit
antiserum on a glass slide. After the slide was tilted gen-
tly for approx. 1 min, the results were read.
Of the 480 colonies screened, a rough strain from pri-
mary screen was further verified by acriflavine agglutin-
ation test.
Identification of transposon insertion site
Chromosomal DNA was isolated from transposon mu-
tant and completely digested with NlaIII that cut on ei-
ther end of the transposon. Meanwhile, an adapter of a
double-stranded cassette was generated as described
previously [11]. Approximately 80 ng purified DNA from
the digested DNA was ligated to 1 μg of the adapter
using a DNA ligation kit (Takara, Dalian, China) in 10 μl
at 16 °C for 12 h. The reaction mixture was diluted with
double distilled water to 100 μl as templates in the PCR
amplification. Sequencing of DNA flanking the trans-
poson was done by Y linker and P6U primer (Table 1).
DNA sequence flanking the transposon insertion site
was identified by BLAST-N alignment with the recently
sequenced SE P125109 in the NCBI GenBank database
(GenBank accession NO. AM933172.1).
Construction of the rfbG gene deletion mutant
The knock-out mutant, SE C50041ΔrfbG was constructed
by λ-Red recombination system [17]. Briefly, the rfbG gene
was first substituted by a PCR adjusted antibiotic resistance
cassette (Cm) using a λ-Red helper plasmid pKD46, which
encode a series of phage recombinase. Recombinant clones
were selected by plating on LB agar containing Cm. To
resolve the antibiotic resistance cassettes (Cm), the
temperature sensitive plasmid pCP20 was introduced. Fi-
nally, the rfbG gene was completely deleted from the start
codon through the stop codon, as confirmed by sequen-
cing. The slide agglutination tests were performed as above
to determine whether SE C50041ΔrfbG was rough strain.
Auto-aggregation assay LPS and SDS-PAGE silver staining
of the mutants
The auto-aggregation assay was performed based on the
method previously described by Zhou et al. [18]. Briefly,
Salmonella cultures were statically grown in 5 ml LB
medium at 37 °C for 16 h in test tubes. The upper 0.2 ml
was carefully removed to measure its optical density
(OD600) (recorded as OD600 prevortex). The remaining
culture in the test tube was then mixed by vortexing to re-
suspend the aggregated cells, and 0.2 ml of the suspension
was removed and its OD600 was measured (recorded as
OD600 postvortex). The “percent aggregation” was calcu-
lated using the formula: 100% *(OD600 postvortex - OD600
prevortex)/OD600 postvortex.
Validation of the LPS phenotype occurred by SDS-
PAGE and silver staining [19]. For this purpose LPS was
isolated from SE C50041 and SE C50041ΔrfbG using a
commercially available LPS extraction kit (Intron bio-
technology, Gyeonggi-do, Korea). The obtained LPS was
separated by standard SDS-PAGE and was stained using
a pierce® silver stain kit (Thermo, Rockford, USA).
Analysis of in vitro growth and biochemical characteristics
of the mutants
For in vitro growth analysis of SE C50041, SE
C50041ΔspiC, SE C50041ΔspiC - rfbG::Tn5Km2(Cm)
and SE C50041ΔrfbG. A single colony of each strain was
subcultured in 5 ml LB broth and cultured at 37 °C with
shaking at 180 rpm for at least 12 h. Subsequently the
absorbance value of each strain was determined by spec-
trophotometry and cultures were diluted in 20 ml LB
broth, then the absorbance value was determined by
spectrophotometry to achieve an approx. initial concen-
tration (OD600 = 0.05) as a starting time point (0 h). The
cultures were incubated at 37 °C with shaking at
100 rpm and the OD600 was determined at time points
of 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 h.
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Each strain was tested in triplicate in two independent
experiments. Biochemical traits of strains were tested by
VITEK® 2 microbial identification system (bioMérieux,
Marcy l'Etoile, France), including glucose, maltose, su-
crose, mannose, mannitol, lactose, dulcitol, adonitol,
sorbitol, malonate, lysine decarboxylase, ornithine de-
carboxylase, urea, H2S and so on.
Motility Assay
LB plates containing 0.3% (w/v) agar was used to
characterize the motility phenotype of SE C50041, SE
C50041ΔspiC, SE C50041ΔspiC - rfbG::Tn5Km2(Cm)
and SE C50041ΔrfbG. Overnight cultures of each strain
were adjusted to the same optical density. Equal volume
of suspensions were incubated on spots onto 0.3% LB
agar. The plates were incubated at 37 °C for 5 h, and
motility was assessed by examining the migration of
the bacteria from the center of the inoculation point
to the periphery of the plate [20]. The data were rep-
resentative of three independent experiments, which
gave similar results.
Preparation and identification of sera
The SPF chickens were obtained from Poultry Insti-
tute of Shandong Academy of Agricultural Science
and the chickens were detected for free from any
clinical signs of enteric disease and negative for
Salmonella. All chickens were given formulated com-
mercial feed and water throughout the experimental
period. Experiments were undertaken in accordance
with the permission of the Animal Care and Ethics
Committee of Yangzhou University.
Three-week-old chickens were inoculated intramuscu-
larly with 100 μl of bacteria suspended in PBS solution
and then a boost on day 14 after the first immunization,
each bacteria inoculum was 1 × 108 CFU (intramuscu-
larly, n = 5). Chickens were immunized respectively with
SE C50041ΔspiC, SE C50041ΔspiC - rfbG::Tn5Km2(Cm)
or SE C50041ΔrfbG. A group of chickens was also in-
fected with wild-type strain SE C50041. Five control
chickens received 100 μl of PBS via the same route. Sera
from each animals (20 μl) were mixed with some SE
C50041 and observed for agglutination reaction [4].
The flocktype® Salmonella Ab ELISA kit (QIAGEN,
Leipzig, Germany) was also used to determine the pres-
ence of serum antibody to the O-antigens 1, 4, 5, 9, and
12 as handbook indicated. An S/P ratio of ≥0.3 was con-
sidered positive while <0.2 was considered negative,
samples with the S/P ratio ≥0.2 and <0.3 are doubtful.
Virulence assessment
BALB/c mice were obtained from the experimental ani-
mal centre of Yangzhou University. The mice were
housed in an animal facility under a standard animal
study protocol. Experiments were undertaken in accord-
ance with the permission of the Animal Care and Ethics
Committee of Yangzhou University.
To investigate the virulence of SE C50041ΔrfbG in
BALB/c mice (6 - 8 weeks of age), Two groups of mice
(each containing 25 mice) were infected with SE
C50041ΔrfbG and SE C50041. Mice in each group were
further subdivided into five subgroups, each containing
five mice. Each mouse in the C50041ΔrfbG group was
injected intraperitoneally with 10-fold dilutions of the
strain from 1 × 108 - 1 × 104 CFU in 100 μl PBS. Each
mouse in the C50041 groups was injected intraperitone-
ally with 10-fold dilutions of the strain from 1 × 104 -
1 × 100 CFU in 100 μl PBS. Five control mice received
100 μl of PBS via the same route. Deaths were recorded
up to day 14 and the LD50 of each strain was calculated
using the Karber and Behrens method [21].
Statistical analysis
All statistical analyses were performed using GraphPad
Prism. P values < 0.05 were considered significant when
using one-way analysis of variance (ANOVA).
Results
Identification of mutant S. Enteritidis showing smooth-to-
rough phenotype
Out of 480 mutants screened, 1 potential mutant was
not agglutinated with O9 MAb or O9 factor rabbit anti-
serum. To confirm that the transposon mutant had a
rough phenotype, an acriflavine agglutination test was
performed and the result showed that this strain was
strongly agglutinated with acriflavine (Fig. 1a).
The sequence of the DNA flanking the transposon in-
sertion site from this rough mutant was identified to be
rfbG (region from 2176901 to 2177980 in SE P125109),
which encodes a putative CDP-glucose 4,6-dehydratase.
Deleted mutant ΔrfbG of S. Enteritidis becoming rough
pattern
The deletion mutant ΔrfbG of S. Enteritidis was con-
structed by λ-Red recombination system. The slide
agglutination tests showed that SE C50041ΔrfbG was
not agglutinated with O9 MAb or O9 factor rabbit
antiserum, but was agglutinated with acriflavine
(Fig. 1a). SE C50041ΔrfbG also demonstrated smooth-
rough transition.
Auto-aggregation of ΔrfbG mutants and SDS-PAGE silver
staining of LPS
The auto-aggregation was tested in Luria-Bertani (LB)
broth (Fig. 1b) and the “percent aggregation” was calcu-
lated using OD450 measurements from these cultures.
Both the SE C50041 and SE C50041ΔspiC showed 5% ag-
gregation, then the SE C50041ΔrfbG and SE C50041ΔspiC
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- rfbG::Tn5Km2(Cm) demonstrated 48% and 69% aggre-
gation, respectively (Fig. 1b).
LPS patterns obtained by standard Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
of SE C50041, SE C50041ΔspiC, SE C50041ΔspiC -
rfbG::Tn5Km2(Cm) and SE C50041ΔrfbG are presented
in Fig. 1a. It showed a visible loss of O-antigens and
Core-LPS antigens for ΔrfbG mutants (SE C50041ΔrfbG
and SE C50041ΔspiC - rfbG::Tn5Km2(Cm)) compared
to SE C50041 or SE C50041ΔspiC. There was no obvious
difference between ΔrfbG mutant and SE C50041ΔspiC -
rfbG::Tn5Km2(Cm) (Fig. 1c).
Growth and biochemical characteristics of ΔrfbG mutants
Growth curve analysis revealed no significant differ-
ences between the wild-type and each mutant when
cultured in LB broth at 37 °C (Fig. 2). Results of bio-
chemical tests including glucose, maltose, sucrose,
mannose, mannitol, lactose, dulcitol, adonitol, sorbitol,
malonate, lysine decarboxylase, ornithine decarboxyl-
ase, urea, H2S and so on were the same between
wild-type and each mutant, suggesting mutations in
these genes do not alter the biochemical characteris-
tics of S. Enteritidis.
Motility of ΔrfbG mutants
Motility plates (Fig. 3) displayed a marked reduction in
migration from the inoculation site to the periphery of the
plate for SE C50041ΔrfbG (2.5 mm) and SE C50041ΔspiC
- rfbG::Tn5Km2(Cm) (3.0 mm) when compared to SE
C50041 (15.5 mm) and SE C50041ΔspiC (14.5 mm). The
data were representative of three independent experi-
ments, which gave similar results.
Sera tests
Sera samples were collected at 14 days after the second
immunization with SE C50041ΔspiC, SE C50041ΔspiC -
rfbG::Tn5Km2(Cm), SE C50041ΔrfbG, SE C50041 or
PBS control. Sera collected from SE C50041ΔspiC -
rfbG::Tn5Km2(Cm), SE C50041ΔrfbG and control
groups were not agglutinated with SE C50041. In
Fig. 1 Rough strain characteristics of ΔrfbG mutants. a SDS-PAGE with silver staining of LPS of ΔrfbG mutants (SE C50041ΔrfbG and SE C50041ΔspiC -
rfbG::Tn5Km2(Cm)) compared to SE C50041 or SE C50041ΔspiC. b Agglutination was examined with O9 MAb, O9 factor rabbit antiserum and acriflavine.
Pictures were taken within 5 min. c Visual aggregation and “percent aggregation” of ΔrfbG mutants (SE C50041ΔrfbG and SE C50041ΔspiC -
rfbG::Tn5Km2(Cm)), SE C50041 and SE C50041ΔspiC cultures grown statically for 16 h at 37 °C. 1, SE C50041; 2, SE C50041ΔrfbG; 3, SE C50041ΔspiC; 4,
SE C50041ΔspiC - rfbG::Tn5Km2(Cm)
Fig. 2 Growth curves of ΔrfbG mutants. The SE C50041, SE C50041ΔrfbG,
SE C50041ΔspiC and SE C50041ΔspiC - rfbG::Tn5Km2(Cm) showed an
identical growth response in LB broth
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contrast, sera collected from the other two groups
showed obvious reaction (Table 2).
Sera samples of chicks immunized with ΔrfbG mutants
(SE C50041ΔspiC - rfbG::Tn5Km2(Cm) (n = 5) or SE
C50041ΔrfbG (n = 5)) and control animals (n = 5) were
considered Salmonella negative when using a commer-
cially available flocktype® Salmonella Ab ELISA kit.
Chicks immunized with SE C50041ΔspiC (n = 5) or SE
C50041 (n = 5) were considered seropositive for Salmon-
ella in the ELISA test (Table 2). In conclusion, ΔrfbG
mutants without O-antigen do not stimulate animals to
produce relevant antibody.
Virulence of ΔrfbG mutant
To investigate the role of rfbG on the virulence, mice
were injected intraperitoneally with SE C50041ΔrfbG
and SE C50041, and half-lethal dose (LD50) values were
calculated according to the method of Karber and
Behrens. The LD50 of ΔrfbG was 10
6.69, which was 106.6
-fold higher than that of SE C50041(100.13), implying
that the virulence of the SE C50041ΔrfbG was signifi-
cantly decreased (P < 0.05).
Discussion
For gram-negative bacteria, including Salmonella, LPS
are essential components of immunodominant antigens.
For Salmonella, some LPS deficient mutants represent a
promising research area. These mutants can not only
result in attenuation, but also show structural (smooth-
rough) transition that can be used as a marker for distin-
guishing isolates [19]. Therefore, the present study was
performed to identify novel factors of S. Enteritidis that
are important for smooth-to-rough transition.
STM is a powerful genetic tool that allows identifica-
tion of genes that are important for different facets of
pathogenesis and is well suited for screening rough
strain in vitro. In this study, we first attempted to use O9
MAb and O9 factor rabbit antiserum to screen for
signature-tagged transposon mutants of S. Enteritidis
with slide agglutination tests. We found that rfbG gene
was involved in smooth-to-rough transition in S. Enteri-
tidis. Meanwhile, we also identified some other genes
that involved in smooth-to-rough transition, e.g., rfc
(data not shown), which has been used as a marker for
distinguishing in Salmonella enterica vaccine research
[22, 23]. In line with this, this new approach of using O9
MAb and O9 factor rabbit antiserum to screen S. Enteri-
tidis signature-tagged transposon mutants to identify
novel loci involved in smooth-to-rough transition is use-
ful and reliable.
The rfb gene cluster of S. Typhimurium contains genes
that are responsible for all or part of the biosynthetic path-
ways of dTDP-L-rhamnose, ODP-abequose and GDP-
mannose, and are essential for O-antigen biosynthesis.
Among them, the rfbG gene, which encodes a CDP-
glucose 4,6-dehydratase, is a component of abequose bio-
synthetic pathway. CDP-glucose 4,6-dehydratase and
glucose-1-phosphate cytidylyltransferase (rfbF) are two
enzymes required to promote the formation of CDP-4-
keto-3,6-dideoxyglucose from CDP-4-keto-6-deoxyglu-
cose (rfbH and rfbI), and abequose synthase (rfbJ) [24].
On the basis of amino-acid sequence homology, S. Typhi
CDP-glucose 4,6-dehydratase is known to be a member of
the short-chain dehydrogenase/reductase(SDR) superfam-
ily, with the N-terminal domain contains a Rossmann fold
and provides the platform for NAD(H) binding. The C-
terminal domain is composed mostly of α-helix and
houses the bingding pocket for the CDP portion of the
CDP-xylose ligand. The xylose moiety extends into the
active-site cleft that is located between the two domains
[25]. It has also been demonstrated that the rfbG-negative
Azotobacter vinelandii grown in liquid medium exhibited
Fig. 3 Motility assay of ΔrfbG mutants. Motility assay of the SE C50041, SE
C50041ΔspiC, SE C50041ΔspiC - rfbG::Tn5Km2(Cm) and SE C50041ΔrfbG. S.
Pullorum S06004, was used as a negative control on swimming agar.
After 5 h of incubation at 37 °C on swimming plates, the semi-diameter
of each bacterial growth area was measured. These results shown are
representative of three independent experiments. The migrations of
strains are highlight using red arrows
Table 2 Positive rate of sera tests (agglutination and ELISA)
Strains Agglutination ELISA
SE C50041 5/5 5/5
SE C50041ΔspiC 5/5 5/5
SE C50041ΔrfbG 0/5 0/5
SE C50041ΔspiC - rfbG::Tn5Km2(Cm) 0/5 0/5
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agglutination, suggesting that rfbG gene is involved in sur-
face structural transition [26].
It has been described that some LPS deficient mutants
(rfaJ, rfaL, rfc, et al.) were used in Salmonella DIVA-
vaccine (Differentiation of Infected and Vaccinated Ani-
mals) research [19, 27, 28]. In the present study, the
virulence change of the rfbG mutant strain were mea-
sured in mouse model. The result demonstrated that
rfbG mutant strain is safe to mammal. Furthermore, SE
Slide Agglutination test and ELISA test showed that
rfbG mutants do not stimulate animals to produce ag-
glutinating antibody, which may help to distinguish ani-
mals vaccinated with this mutant from those infected by
field strains. Overall, rfbG mutant showed a potential
“DIVA” capacity. Nevertheless, as a candidate vaccine,
rfbG mutant needs further study.
In addition, results obtained from motility assays indi-
cate that the deletion of rfbG gene resulted in variation
in swimming motility, suggesting that flagellar assembly
and function may be influenced by the altered LPS
structures. Deditius et al. described that a rfaG mutant
diminished flagellar assembly and significantly reduced
transcription of flagellar class II and class III promoters,
but not of the class I promoter. Moreover, FlhC protein
levels were reduced in the rfaG mutant strain. They con-
cluded that a defect in LPS biosynthesis regulates motil-
ity by affecting FlhDC stability or translation of its
mRNA on a posttranscriptional level via an unknown
mechanism [29]. Moreover, the results obtained from
SDS-PAGE silver staining of LPS show that ΔrfbG mu-
tants not only lead to loss of O-antigens but also lead to
loss of Core-LPS antigens. It suggested that deficiency in
rfbG leads to deep loss of LPS synthesis. The mechanism
of rfbG affect LPS biosynthesis need further studies.
Conclusions
We used O9 MAb and O9 factor rabbit antiserum to
screen S. Enteritidis signature-tagged transposon mu-
tants to identify novel factors involved in smooth-to-
rough transition. The present study demonstrated that
rfbG gene inserted/deletion mutant of S. Enteritidis
showed almost the same biological characteristics, at-
tenuation, distinguishable reaction (agglutination and
ELISA) and other rough strain characteristics. Thus,
this approach may be used more broadly in exploring
LPS biosynthesis, and as a high-throughput tool for
screening rough strains which were used as markers
in developing DIVA-vaccine.
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